mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.6 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
VX-680 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.6 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
darinaparsin |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.6 |
mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.6 |
mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
bafilomycin A1 |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.6 |